UC-MSC-primed CD4+CD25+CD127low/− Tregs from MS significantly inhibited the proliferation of allogeneic CD4+CD25- Teffs from heathy donors (Figure 2A) and autologous CD4+CD25- Teffs from the same MS patients (Figure 2E). This evidence concerns the gene CD4 and myeloid sarcoma.